E. Becker

Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer

V. Budach, K. Wernecke, D. Boehmer, 2014, Strahlentherapie und Onkologie.

Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence.

W. Weichert, A. Stenzinger, V. Budach, 2015, European journal of cancer.

Standard or split TPF induction chemotherapy followed by bioradiation: ICRAT randomized phase II study.

V. Budach, I. Tinhofer, S. Tribius, 2016 .

Expression of collagens in the otosclerotic bone.

W. Arnold, E. Becker, H. Niedermeyer, 2007, Advances in oto-rhino-laryngology.

Hepatocyte Growth Factor Receptor overexpression predicts reduced survival but its targeting is not effective in unselected HNSCC patients

Helge G. Roider, O. von Ahsen, T. Krahn, 2020, Head & neck.

STREPTOCOCCAL NUCLEASES

O. von Ahsen, T. Krahn, W. Yasmineh, 1967, The Journal of experimental medicine.

Adjuvant simultaneous integrated boost IMRT for patients with intermediate- and high-risk head and neck cancer: outcome, toxicities and patterns of failure.

S. Marnitz, V. Budach, I. Tinhofer, 2014, Oral oncology.

EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication

O. von Ahsen, T. Krahn, S. S. Khaznadar, 2018, Oncotarget.